Pandemic Influenza Vaccination Elicits Influenza-Specific CD4 + Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports

Scandinavian Journal of Immunology

Volumn 74, Issue 2, 2011, Pages 210-218

  Pedersen, G ^a   Halstensen, A ^a,b   Sjursen, H ^a,b   Naess A ^a   Kristoffersen, E K ^a,b   Cox, R J ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMANORM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; INFLUENZA VACCINE; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTHRALGIA; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMMON VARIABLE IMMUNODEFICIENCY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMORAL IMMUNITY; MALE; MEMORY CELL; MYALGIA; PAIN; PANDEMIC INFLUENZA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REDDENING; SHIVERING; SIDE EFFECT; SWEATING; SWELLING; TH1 CELL; VACCINATION; X LINKED AGAMMAGLOBULINEMIA;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGAMMAGLOBULINEMIA; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; CLINICAL TRIALS AS TOPIC; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MIDDLE AGED; PANDEMICS; T-LYMPHOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 79960081832     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02561.x     Document Type: Article

References (40)

1. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22years. J Allergy Clin Immunol 2010;125:1354-60 e4.
2. Conley ME, Broides A, Hernandez-Trujillo V et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev 2005;203:216-34.
3. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995;333:431-40.
4. Doyle SL, Jefferies CA, Feighery C, O'Neill LA. Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. J Biol Chem 2007;282:36953-60.
5. Shyur SD, Hill HR. Recent advances in the genetics of primary immunodeficiency syndromes. J Pediatr 1996;129:8-24.
6. WHO. Primary immunodeficiency diseases. Report of a WHO Scientific Group. Clin Exp Immunol 1995;99 (Suppl. 1):1-24.
7. Yarchoan R, Schneider HS, Wray BB, Nelson DL. Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia. J Clin Invest 1983;71:1720-7.
8. Goldacker S, Draeger R, Warnatz K et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol 2007;124:294-303.
9. Lazar A, Wright PF. Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection. Infect Immun 1980;27:867-71.
10. Slifka MK, Shen H, Matloubian M, Jensen ER, Miller JF, Ahmed R. Antiviral cytotoxic T cell memory by vaccination with recombinant Listeria monocytogenes. J Virol 1996;70:2902-10.
11. Graham MB, Braciale TJ. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 1997;186:2063-8.
12. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984;160:814-26.
13. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T cell responses during chronic viral infection. J Virol 1994;68:8056-63.
14. Anderson J, Byrne JA, Schreiber R, Patterson S, Oldstone MB. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties. J Virol 1985;53:552-60.
15. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
16. Darrah PA, Patel DT, De Luca PM et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007;13:843-50.
17. de Goer de Herve MG, Dembele B, Vallee M, Herr F, Cariou A, Taoufik Y. Direct CD4 help provision following interaction of memory CD4 and CD8 T cells with distinct antigen-presenting dendritic cells. J Immunol 2010;185:1028-36.
18. Su HC, Cousens LP, Fast LD et al. CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. J Immunol 1998;160:5007-17.
19. Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 2007;6:300-5.
20. Durando P, Fenoglio D, Boschini A et al. Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. Clin Vaccine Immunol 2008;15:253-9.
21. Zand MS. Safety and efficacy of influenza vaccination in renal transplant recipients. Nat Clin Pract Nephrol 2008;4:358-9.
22. Warnatz K, Denz A, Drager R et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002;99:1544-51.
23. Madhun AS, Akselsen PE, Sjursen H et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 2010;29:266-73.
24. Products EAftEoM. Note for guidance on harmonization of requirements for influenza vaccines (CPMP/BWP/214/96). 1997.
25. de Lavallade H, Garland P, Sekine T et al. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica 2011;96:307-14.
26. Crum-Cianflone NF, Eberly LE, Duplessis C et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis 2011;52:138-46.
27. Rezaei N, Aghamohammadi A, Siadat SD et al. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 2007;25:5308-14.
28. Plebani A, Fischer MB, Meini A, Duse M, Thon V, Eibl MM. T cell activity and cytokine production in X-linked agammaglobulinemia: implications for vaccination strategies. Int Arch Allergy Immunol 1997;114:90-3.
29. Fischer MB, Hauber I, Vogel E, Wolf HM, Mannhalter JW, Eibl MM. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol 1993;92:340-52.
30. Fischer MB, Hauber I, Eggenbauer H et al. A defect in the early phase of T cell receptor-mediated T cell activation in patients with common variable immunodeficiency. Blood 1994;84:4234-41.
31. Pastorelli G, Roncarolo MG, Touraine JL, Peronne G, Tovo PA, de Vries JE. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol 1989;78:334-40.
32. Topham DJ, Tripp RA, Hamilton-Easton AM, Sarawar SR, Doherty PC. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J Immunol 1996;157:2947-52.
33. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. Memory CD4 T cells Direct Protective Responses to Influenza Virus in the Lung through Helper-independent Mechanisms. J Virol 2010;84:9217-26.
34. Zhong W, Roberts AD, Woodland DL. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. J Immunol 2001;167:1379-86.
35. Raeiszadeh M, Kopycinski J, Paston SJ et al. The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin Exp Immunol 2006;146:234-42.
36. North ME, Ivory K, Funauchi M, Webster AD, Lane AC, Farrant J. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 1996;105:517-22.
37. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
38. Mouillot G, Carmagnat M, Gerard L et al. B-cell and T cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 2010;30:746-55.
39. Paroli M, Accapezzato D, Francavilla V et al. Long-lasting memory-resting and memory-effector CD4+ T cells in human X-linked agammaglobulinemia. Blood 2002;99:2131-7.
40. Morales-Aza B, Glennie SJ, Garcez TP et al. Impaired maintenance of naturally acquired T cell memory to the meningococcus in patients with B-cell immunodeficiency. Blood 2009;113:4206-12.